Cleared Traditional

K152204 - VS3-IR system

K152204 is an FDA 510(k) clearance for VS3-IR system, manufactured by Visionsense, Ltd.. The device is a Class 2 General & Plastic Surgery device with product code OWN cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
83d
Days
Class 2
Risk

K152204 is an FDA 510(k) clearance for the VS3-IR system. Classified as Confocal Optical Imaging (product code OWN), Class II - Special Controls.

Submitted by Visionsense, Ltd. (Petach Tikva, Hamerkaz, IL). The FDA issued a Cleared decision on October 28, 2015 after a review of 83 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Visionsense, Ltd. devices

FDA 510(k) Submission Details - K152204

510(k) Number K152204 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2015
Decision Date October 28, 2015
Days to Decision 83 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 115d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OWN Device Classification - Class 2, Special Controls

Product Code OWN Confocal Optical Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Collection Of Light Signals For Visualization Of Cellular Microstructures.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Licensale, Inc.
RAYMOND KELLY

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OWN Confocal Optical Imaging

All 62
Devices cleared under the same product code (OWN) and FDA review panel - the closest regulatory comparables to K152204.
KARL STORZ Endoscopic ICG Imaging System
K152583 · KARL STORZ Endoscopy-America, Inc. · May 2016
CystoFlex UHD R-C, CelioFlex UHD 5-C, Cellvizio 100 Series (800) with Confocal Miniprobes
K160416 · Mauna Kea Technologies · May 2016
Cellvizio 100 Series System with Confocal Miniprobes
K150831 · Mauna Kea Technologies · Dec 2015
Cellvizio 100 Series System with Confocal Miniprobes
K151593 · Mauna Kea Technologies · Oct 2015
Artemis Hand Held Imaging System
K143474 · Quest Medical Imaging · Jun 2015
VS3-IR-MMS System
K150018 · Visionsense, Ltd. · Jun 2015